Petr Szturz

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey.

|May 16, 2025
Navigating challenging patient factors in systemic therapy for head and neck cancer.

Petr Szturz, Robert I Haddad, Marshall Posner

|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.

Susana Banerjee, Eleonora Ghisoni, Anita Wolfer

|Jul 29, 2023
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.

Anagha Gogate, Bryan Bennett, Zia Poonja

|Jan 08, 2023
Estimating the Prevalence of a True Oligometastatic Disease.

Petr Szturz, Pierluigi Bonomo, Jan B Vermorken

|Aug 25, 2022
The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program Results of a Survey on Daily Practice Patterns for Patients with Metastatic Colorectal Cancer-A Swiss Perspective in the Context of an International Viewpoint.

Alexander R Siebenhüner, Giorgia Lo Presti, Daniel Helbling

Pageof 2

Frequent Collaborators

3 joint publications

Jan B Vermorken

1 joint publications

Sara De Dosso

1 joint publications

Pierluigi Bonomo

1 joint publications

Anagha Gogate